Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|April 25, 2019
Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trialsVladimir Gilca, Chantal Sauvageau, Gitika Panicker, et al.Human Vaccines & Immunotherapeutics|September 24, 2019
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trialsChantal Sauvageau, Gitika Panicker, Elizabeth R Unger, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2019
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling studyMélanie Drolet, Zhou Zhou, Chantal Sauvageau, et al.Vaccine|June 12, 2018
Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impactVladimir Gilca, Jorge Salmerón-Castro, Chantal Sauvageau, et al.Human Vaccines & Immunotherapeutics|August 19, 2021
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active womenChantal Sauvageau, Vladimir Gilca, Manale Ouakki, et al.BMC Infectious Diseases|July 9, 2005
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic reviewBa' Pham, Bernard Duval, Gaston De Serres, et al.Vaccine|February 5, 2026
Long-term immunogenicity of alternative HPV vaccine schedules and the effect of an additional dose given three to five years post-primary vaccinationChantal Sauvageau, Iulia G Ionescu, Manale Ouakki, et al.Vaccine|October 31, 2025
Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccinationChantal Sauvageau, Iulia Gabriela Ionescu, Manale Ouakki, et al.BMC Public Health|December 7, 2016
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal studySamara Perez, Ovidiu Tatar, Gilla K Shapiro, et al.Human Vaccines & Immunotherapeutics|February 26, 2015
The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccineVladimir Gilca, Chantal Sauvageau, Nicole Boulianne, et al.Pageof 7